- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
17
Stocks where the price continues to rise after more than a year of consistent gains.
17 companies
AtaiBeckley
Market Cap: US$2.7b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.
ATAI
US$7.22
7D
45.3%
1Y
104.5%
Iovance Biotherapeutics
Market Cap: US$2.2b
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.
IOVA
US$5.00
7D
23.8%
1Y
100.8%
CareDx
Market Cap: US$2.1b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$39.73
7D
38.1%
1Y
211.6%
Harbin Pharmaceutical Group
Market Cap: CN¥13.4b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥5.31
7D
43.1%
1Y
32.8%
Gansu Longshenrongfa Pharmaceutical IndustryLTD
Market Cap: CN¥3.7b
Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.
300534
CN¥12.04
7D
33.8%
1Y
16.3%
Valerio Therapeutics Société anonyme
Market Cap: €304.7m
A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.
ALVIO
€0.83
7D
107.5%
1Y
1,409.1%
GlaxoSmithKlineE
Market Cap: ج.م10.6b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م126.84
7D
72.3%
1Y
186.3%
Great Novel Therapeutics Biotech & Medicals
Market Cap: NT$3.3b
Engages in the development of drugs for the treatment of advanced and refractory cancers in Taiwan.
7427
NT$78.30
7D
56.3%
1Y
108.8%
October PharmaE
Market Cap: ج.م5.1b
Manufactures and sells pharmaceutical products in Egypt.
OCPH
ج.م427.02
7D
20.3%
1Y
242.5%
New Green Hemp
Market Cap: US$48.5m
New Green Hemp Inc. cultivates and sells hemp products.
NGHI
US$1.92
7D
28.9%
1Y
175.4%
Dyadic International
Market Cap: US$45.9m
A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.
DYAI
US$1.26
7D
23.5%
1Y
26.0%
Apollomics
Market Cap: US$40.7m
A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
APLM
US$18.52
7D
30.3%
1Y
162.0%
Stem Cells Spin
Market Cap: zł20.7m
Operates as a biotechnology company in Poland.
SCS
zł0.54
7D
44.4%
1Y
76.5%
Blueberries Medical
Market Cap: CA$7.4m
A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.
BBM
CA$0.015
7D
50.0%
1Y
50.0%
BPH Global
Market Cap: AU$4.7m
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
BP8
AU$0.002
7D
33.3%
1Y
0%
Innovation Pharmaceuticals
Market Cap: US$1.6m
A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.
IPIX
US$0.003
7D
900.0%
1Y
900.0%
OWC Pharmaceutical Research
Market Cap: US$5.0k
Through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products.
OWCP
US$0.00001
7D
900.0%
1Y
900.0%